This is Hansa
Our therapeutic areas
Our technology platform
Our pipeline and products
Career
Investors
Media
Contacts
18 Apr 2024
Interim report January-March 2024
E-mail
I consent to Hansa Biopharma handling my personal data. See our Privacy Policy for information about how we handle personal data.